Monoclonal antibody against H1N1 influenza virus hemagglutinin cross reacts with hnRNPA1 and hnRNPA2/B1

Guo,Chunyan; Sun,Lijun; Hao,Shuangping; Huang,Xiaoyan; Hu,Hanyu; Liang,Daoyan; Feng,Qing; Li,Yan; Feng,Yangmeng; Xie,Xin; Hu,Jun

doi:10.3892/mmr.2020.11494

Monoclonal antibody against H1N1 influenza virus hemagglutinin cross reacts with hnRNPA1 and hnRNPA2/B1

Authors:
- Chunyan Guo
- Lijun Sun
- Shuangping Hao
- Xiaoyan Huang
- Hanyu Hu
- Daoyan Liang
- Qing Feng
- Yan Li
- Yangmeng Feng
- Xin Xie
- Jun Hu
View Affiliations

Affiliations: Central Laboratory of Shaanxi Provincial People's Hospital, The Third Affiliated Hospital of Medical School, Xi'an Jiaotong University, Shaanxi Province Research Centre of Cell Immunological Engineering and Technology, Key Laboratory of Microbial Infections and Autoimmune Diseases, Xi'an, Shaanxi 710068, P.R. China, Guangshui Traditional Chinese Medicine Hospital of Hubei Province, Guangshui, Hubei 432700, P.R. China, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA, Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi'an, Shaanxi 710069, P.R. China
Published online on: September 7, 2020 https://doi.org/10.3892/mmr.2020.11494
Pages: 3969-3975
Copyright: © Guo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Following influenza A vaccination, certain individuals exhibit adverse reactions in the nervous system, which causes a problem with the safety of the influenza A vaccine. However, to the best of our knowledge, the underlying mechanism of this is unknown. The present study revealed that a monoclonal antibody (H1‑84mAb) against the H1N1 influenza virus hemagglutinin (HA) protein cross‑reacted with an antigen from brain tissue. Total brain tissue protein was immunoprecipitated with this cross‑reactive antibody, and mass spectrometry revealed that the bound antigens were heterogeneous nuclear ribonucleoprotein (hnRNP) A1 and hnRNPA2/B1. Subsequently, the two proteins were expressed in bacteria and it was demonstrated that H1‑84mAb bound to hnRNPA1 and hnRNPA2/B1. These two proteins were expressed in three segments and the cross‑reactivity of H1‑84mAb with the glycine (Gly)‑rich domains of hnRNPA1 (195aa‑320aa) and hnRNPA2/B1 (202aa‑349aa) was determined using ELISA blocking experiments. It was concluded that the Gly‑rich domains of these two proteins are heterophilic antigens that cross‑react with influenza virus HA. The association between the heterophilic antigen Gly‑rich domains and the safety of influenza A vaccines remains to be investigated.

View Figures

View References

1	Mahmud SM, Bozat-Emre S, Mostaço-Guidolin LC and Marrie RA: Registry cohort study to determine risk for multiple sclerosis after vaccination for pandemic influenza A(H1N1) with Arepanrix, Manitoba, Canada. Emerg Infect Dis. 24:1267–1274. 2018. View Article : Google Scholar : PubMed/NCBI
2	Fukuda M, Yoshida T, Moroki M, Hirayu N, Nabeta M, Nakamura A, Uzu H and Takasu O: Influenza A with hemorrhagic shock and encephalopathy syndrome in an adult: A case report. Medicine (Baltimore). 98:e150122019. View Article : Google Scholar : PubMed/NCBI
3	Siegers JY, van de Bildt MWG, Lin Z, Leijten LM, Lavrijssen RAM, Bestebroer T, Spronken MIJ, De Zeeuw CI, Gao Z, Schrauwen EJA, et al: Viral factors important for efficient replication of influenza A viruses in cells of the central nervous system. J Virol. 93:e02273–18. 2019. View Article : Google Scholar : PubMed/NCBI
4	Ninove L, Daniel L, Gallou J, Cougard PA, Charpentier A, Viard L, Roquelaure B, Paquis-Flucklinger V, de Lamballerie X, Zandotti C and Charrel RN: Fatal case of Reye's syndrome associated with H3N2 influenza virus infection and salicylate intake in a 12-year-old patient. Clin Microbiol Infect. 17:95–97. 2011. View Article : Google Scholar : PubMed/NCBI
5	Francis JR, Richmond P, Robins C, Lindsay K, Levy A, Effler PV, Borland M and Blyth CC: An observational study of febrile seizures: The importance of viral infection and immunization. BMC Pediatr. 16:2022016. View Article : Google Scholar : PubMed/NCBI
6	Cárdenas G, Soto-Hernández JL, Díaz-Alba A, Ugalde Y, Mérida-Puga J, Rosetti M and Sciutto E: Neurological events related to influenza A (H1N1) pdm09. Influenza Other Respir Viruses. 8:339–346. 2014. View Article : Google Scholar : PubMed/NCBI
7	Tin SS and Wiwanitkit V: Neurological complications after H1N1 influenza vaccination. Arq Neuropsiquiatr. 72:9772014. View Article : Google Scholar : PubMed/NCBI
8	Guo CY, Tang YG, Qi ZL, Liu Y, Zhao XR, Huo XP, Li Y, Feng Q, Zhao PH, Wang X, et al: Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus. Immunobiology. 220:941–946. 2015. View Article : Google Scholar : PubMed/NCBI
9	Yamamoto M, Cid E and Yamamoto F: Molecular genetic basis of the human Forssman glycolipid antigen negativity. Sci Rep. 2:9752012. View Article : Google Scholar : PubMed/NCBI
10	Wang JJ, Yang GX, Zhang WC, Lu L, Tsuneyama K, Kronenberg M, Véla JL, Lopez-Hoyos M, He XS, Ridgway WM, et al: Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice. Clin Exp Immunol. 175:192–201. 2014. View Article : Google Scholar : PubMed/NCBI
11	Coppieters KT and von Herrath M: Antibody cross-reactivity and the viral aetiology of type 1 diabetes. J Pathol. 230:1–3. 2013. View Article : Google Scholar : PubMed/NCBI
12	Guo CY, Zhang HX, Zhang JJ, Sun LJ, Li HJ, Liang DY, Feng Q, Li Y, Feng YM, Xie X and Hu J: Localization analysis of heterophilic antigen epitopes of H1N1 influenza virus hemagglutinin. Virol Sin. 34:306–314. 2019. View Article : Google Scholar : PubMed/NCBI
13	Sun L, Li H, Sun J, Guo C, Feng Y, Li Y, Zhao X, Xie X and Hu J: Antibodies against H1N1 influenza virus hemagglutinin cross-react with prohibitin. Biochem Biophys Res Commun. 513:446–451. 2019. View Article : Google Scholar : PubMed/NCBI
14	Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC Jr, Hasty KA, Callaway JC, Zunt J, Desiderio D and Stuart JM: Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med. 8:509–513. 2002. View Article : Google Scholar : PubMed/NCBI
15	Yang L, Tu JL and Xiong YS: Influenza-related central nervous system damage. Chin J Neurol. 43:737–738. 2010.
16	Ahmed SS, Volkmuth W, Duca J, Corti L, Pallaoro M, Pezzicoli A, Karle A, Rigat F, Rappuoli R, Narasimhan V, et al: Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med. 7:294ra1052015. View Article : Google Scholar : PubMed/NCBI
17	Sarkanen TO, Alakuijala APE, Dauvilliers YA and Partinen MM: Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. Sleep Med Rev. 38:177–186. 2018. View Article : Google Scholar : PubMed/NCBI
18	Wekerle H: Vaccination and narcolepsy: Immune link found? Sci Transl Med. 7:1–3. 2015. View Article : Google Scholar
19	Krecic AM and Swanson MS: hnRNP complexes: Composition, structure, and function. Curr Opin Cell Biol. 11:363–371. 1999. View Article : Google Scholar : PubMed/NCBI
20	Levin MC, Lee SM, Gardner LA, Shin Y, Douglas JN and Salapa H: Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered ‘ribostasis’ and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis. J Neuroimmunol. 304:56–62. 2017. View Article : Google Scholar : PubMed/NCBI
21	Douglas JN, Gardner LA, Salapa HE, Lalor SJ, Lee S, Segal BM, Sawchenko PE and Levin MC: Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease. J Neuroinflammation. 13:1782016. View Article : Google Scholar : PubMed/NCBI
22	Sueoka E, Yukitake M, Iwanaga K, Sueoka N, Aihara T and Kuroda Y: Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients. Ann Neurol. 56:778–786. 2004. View Article : Google Scholar : PubMed/NCBI
23	Lee S, Xu L, Shin Y, Gardner L, Hartzes A, Dohan FC, Raine C, Homayouni R and Levin MC: A potential link between autoimmunity and neurodegeneration in immune-mediated neurological disease. J Neuroimmunol. 235:56–69. 2011. View Article : Google Scholar : PubMed/NCBI
24	Mishra S, Murphy LC and Murphy LJ: The prohibitins: Emerging roles in diverse functions. J Cell Mol Med. 10:353–363. 2006. View Article : Google Scholar : PubMed/NCBI
25	Lee SM, Dunnavant FD, Jang H, Zunt J and Levin MC: Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease. Neurosci Lett. 401:188–193. 2006. View Article : Google Scholar : PubMed/NCBI
26	Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM and Crawley R: Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol. 154:2983–2995. 1995.PubMed/NCBI